Pediatric morphea (localized scleroderma): Review of 136 patients

Journal of the American Academy of Dermatology

Volumn 59, Issue 3, 2008, Pages 385-396

  Christen Zaech, Stéphanie ^a   Hakim, Miriam D ^a   Afsar, F Sule ^a   Paller, Amy S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; CORTICOSTEROID; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; DEXAMETHASONE; FLUOCINONIDE; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; NAPROXEN; OMEPRAZOLE; PENICILLAMINE; PREDNISONE; PSORALEN DERIVATIVE; TACROLIMUS; TRIAMCINOLONE;

AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPHAGIA; FAMILY STUDY; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LONG TERM CARE; LUNG DISEASE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORPHEA; MUSCULOSKELETAL DISEASE; ONSET AGE; PRIORITY JOURNAL; PUVA; SAMPLE SIZE; SEX DIFFERENCE; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT; MALE; METHOTREXATE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SEX FACTORS; SKIN;

EID: 48749115529     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.05.005     Document Type: Article

References (35)

1. Murray K.J., and Laxer R.M. Scleroderma in children and adolescents. Rheum Dis Clin North Am 28 (2002) 603-624
2. Marzano A.V., Menni S., Parodi A., Borghi A., Fuligni A., Fabbri P., et al. Localized scleroderma in adults and children: clinical and laboratory investigations on 239 cases. Eur J Dermatol 13 (2003) 171-176
3. Bodemer C., Belon M., Hamel-Teillac D., Amoric J.C., Fraitag S., Prieur A.M., et al. Scleroderma in children: a retrospective study of 70 cases [French]. Ann Dermatol Venereol 126 (1999) 691-694
4. Pope J.E. Scleroderma overlap syndromes. Curr Opin Rheumatol 14 (2002) 704-710
5. Krafchik B.R. Localized morphea in children. Adv Exp Med Biol 455 (1999) 49-54
6. Vierra E., and Cunningham B.B. Morphea and localized scleroderma in children. Semin Cutan Med Surg 18 (1999) 210-225
7. Jablonska S., and Blaszczyk M. Scleroderma overlap syndromes. Adv Exp Med Biol 455 (1999) 85-92
8. Hayakawa I., Hasegawa M., Takehara K., and Sato S. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Arthritis Rheum 50 (2004) 227-232
9. Uziel Y., Krafchik B.R., Silverman E.D., Thorner P.S., and Laxer R.M. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum 23 (1994) 328-340
10. Zulian F., Vallongo C., Woo P., Russo R., Ruperto N., Harper J., et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52 (2005) 2873-2881
11. Mayorquin F.J., McCurley T.L., Levernier J.E., Myers L.K., Becker J.A., Graham T.P., et al. Progression of childhood linear scleroderma to fatal systemic sclerosis. J Rheumatol 21 (1994) 1955-1957
12. Birdi N., Laxer R.M., Thorner P., Fritzler M.J., and Silverman E.D. Localized scleroderma progressing to systemic disease: case report and review of the literature. Arthritis Rheum 36 (1993) 410-415
13. Cunningham B.B., Landells I.D., Langman C., Sailer D.E., and Paller A.S. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 39 (1998) 211-215
14. Hom C., and Ilowite N.T. Other rheumatic diseases in adolescence: dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis. Adolesc Med 9 (1998) 69-83 vi
15. Isenberg D.A., and Black C. ABC of rheumatology: Raynaud's phenomenon, scleroderma, and overlap syndromes. BMJ 310 (1995) 795-798
16. Steen V.D., Oddis C.V., Conte C.G., Janoski J., Casterline G.Z., and Medsger Jr. T.A. Incidence of systemic sclerosis in Allegheny County, Pennsylvania: a twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 40 (1997) 441-445
17. Zulian F., Athreya B.H., Laxer R., Nelson A.M., Feitosa de Oliveira S.K., Punaro M.G., et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children: an international study. Rheumatology (Oxford) 45 (2006) 614-620
18. Peterson L.S., Nelson A.M., Su W.P., Mason T., O'Fallon W.M., and Gabriel S.E. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 24 (1997) 73-80
19. Falanga V., Medsger Jr. T.A., Reichlin M., and Rodnan G.P. Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104 (1986) 849-857
20. Christianson H.B., Dorsey C.S., Kierland R.R., and O'Leary P.A. Localized scleroderma; a clinical study of two hundred thirty-five cases. AMA Arch Derm 74 (1956) 629-639
21. Bastian H.M., Alarcon G.S., Roseman J.M., McGwin Jr. G., Vila L.M., Fessler B.J., et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 46 (2007) 683-689
22. Krishnan E., and Hubert H.B. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 65 (2006) 1500-1505
23. Uziel Y., Feldman B.M., Krafchik B.R., Yeung R.S., and Laxer R.M. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 136 (2000) 91-95
24. Weibel L., Sampaio M.C., Visentin M.T., Howell K.J., Woo P., and Harper J.I. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children. Br J Dermatol 155 (2006) 1013-1020
25. Fitch P.G., Rettig P., Burnham J.M., Finkel T.H., Yan A.C., Akin E., et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 33 (2006) 609-614
26. Mitchell H., Bolster M.B., and LeRoy E.C. Scleroderma and related conditions. Med Clin North Am 81 (1997) 129-149
27. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La Montagna G., et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81 (2002) 139-153
28. Jaffe M.O., and Winkelmann R.K. Generalized scleroderma in children: acrosclerotic type. Arch Dermatol 83 (1961) 402-413
29. Goel K.M., and Shanks R.A. Scleroderma in childhood: report of 5 cases. Arch Dis Child 49 (1974) 861-866
30. Bourgeois-Droin C., and Touraine R. Scleroderma in plaques: immunological and visceral disturbances [French]. Ann Med Interne (Paris) 129 (1978) 107-112
31. Tangsrud S.E., Skyberg D., and Larsen T.E. Scleroderma with massive regional lymphadenopathy. Acta Paediatr Scand 68 (1979) 627-628
32. Person J.R., and Su W.P. Subcutaneous morphea: a clinical study of sixteen cases. Br J Dermatol 100 (1979) 371-380
33. Torok E., and Ablonczy E. Morphea in children. Clin Exp Dermatol 11 (1986) 607-612
34. Larregue M., Ziegler J.E., Lauret P., Bonafe J., Lorette G., Titi A., et al. Linear scleroderma in children (apropos of 27 cases) [French]. Ann Dermatol Venereol 113 (1986) 207-224
35. Woo T.Y., and Rasmussen J.E. Juvenile linear scleroderma associated with serologic abnormalities. Arch Dermatol 121 (1985) 1403-1405